baber/WOPTO huggingface dataset:
Patent NZ-551531-A (NZ)
Title: Plastics material
Inventor: VERBEEK CASPARUS JOHANNES REINHARD
Filed: 2006-11-22
Abstract: Disclosed is a method of manufacturing a plastic material from blood meal, the method characterised by the following steps; i) treating the blood meal with at least three denaturing agents, including SDS or equivalent thereof, urea or equivalent thereof and sodium sulfite or equivalent thereof, to break interactions between proteins or portions thereof, and ii) treating the denatured protein source with sufficient pressure and temperature to consolidate the denatured protein source into a plastic material.
Patent NZ-552866-A (NZ)
Title: Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
Inventor: CUI JINGRONG JEAN
IPC: C07D241/20
Filed: 2005-08-15
Abstract: Enantiomerically pure aminoheteroaryl compounds of formula (I) are disclosed, as well as methods for their synthesis and use; wherein the variables are as defined in the specification. These preferred compounds are potent inhibitors of the c-Met protein kinase, and are useful in the treatment of abnormal cell growth disorders, such as cancers.
Patent NZ-553889-A (NZ)
Title: Replication-defective adenovirus comprising a chimeric hexon protein and replaced hypervariable ragions HVR1-7
Inventor: HAVENGA MENZO JANS EMCO
IPC: A61K48/00
Filed: 2005-10-12
Abstract: Disclosed are recombinant adenoviruses that are designed to avoid pre-existing immunities in the host, but which are still capable of inducing strong immune responses against the proteins encoded by the nucleic acids which they carry. In particular, the adenoviruses are based on Ad5, characterised in that the adenoviruses comprise a chimeric hexon protein wherein the seven hypervariable regions HVR1 to HVR7 are replaced with HVR sequences disclosed herein.
Patent NZ-554007-A (NZ)
Title: Gas flow control method in a blower based ventiliation system
Inventor: LI KUN
IPC: A61M16/00
Filed: 2005-09-21
Abstract: A system for controlling the rate of gas flow induced by a variable speed fan in a breathing assistance system comprises means for receiving a user setting for a target flow rate; means for measuring a back pressure experienced by the fan; means for calculating a target fan speed for producing the target flow rate set by the user based at least on the measured back pressure; and means for controlling the variable speed fan based at least on the calculated target fan speed. Further disclosed is a system for of controlling the rate of gas flow induced by a fan including a fan outlet in a breathing assistance system. The system comprises means for setting a target gas flow rate; means for setting a time span for the gas flow rate; means for calculating a first fan speed to induce the target flow rate within the time span; means for adjusting the fan based at least on the first fan speed; means for measuring a first gas flow rate generated by the fan at the conclusion of the time span; means for measuring a first back pressure experienced at the fan outlet at the conclusion of the time span; means for calculating a second fan speed based at least on the first gas flow rate and the first back pressure to correct for the difference between the first gas flow rate and the target gas flow rate; and means for adjusting the fan based at least on the second fan speed.
Patent NZ-555238-A (NZ)
Title: Complex containing mequitazine, a cyclodextrin and an interaction agent
Inventor: FREISS BERNARD
IPC: A61K31/5415
Filed: 2005-10-19
Abstract: Disclosed is a complex that includes mequitazine, a cyclodextrins, and an interaction agent as herein defined which is a base wherein the rate of solubilization in water of complexed mequitazine, measured for a 2 g/l mixture of mequitazine in water at 35 degrees Celsius after 15 minutes of stirring, is greater than 50% at pH 9. Also disclosed is a process of making said complex.
Patent NZ-567011-A (NZ)
Title: Multiple directional wheel including frame and rollers
Inventor: GUILE GRAHAM
IPC: B62B7/04
Filed: 2003-08-07
Abstract: A wheel (10) able to travel in more than one direction is disclosed. The wheel is rotatable about a main axis and includes a series of rollers aligned in a plane normal to the axis. The wheel has a frame (11) with a plurality of supports (15), where each roller is mounted on a corresponding roller axle (16) extending between adjacent supports. Each roller axle is linear and integral with the supports to form a continuous ring of material about the periphery of the frame.
Patent NZ-572051-A (NZ)
Title: An explosion proof material made by rolling up a perforated mesh sheet and inserting a skeleton in the gaps between the layers
Inventor: HUANG XIAODONG
IPC: B60K15/077
Filed: 2007-07-31
Abstract: An explosion-proof material composed of a perforated mesh sheet 11, the perforated mesh sheet 11 being rolled up into a multilayer material body 1 with one side edge 12 of it as centre, and along the direction perpendicular to this side edge 12. A skeleton 13 is inserted in the gaps between any two layers of the multilayer perforated mesh sheet 11 for fixing and supporting the material body
Patent NZ-578650-A (NZ)
Title: Pd-1 and activated t-cell compositions and methods for the treatment of viral infections and tumors
Inventor: AHMED RAFI
IPC: A61K39/00
Filed: 2007-12-26
Abstract: Use of activated T-cells that specifically recognise a viral antigen of interest and a PD-1 antagonist for inducing an immune response to the viral antigen of interest in a mammalian subject having a persistent or chronic viral infection. The viral antigen can be gp33 from the hepatitis virus or gp120 from HIV. The PD-1 antagonist can be an anti-PD-1, anti-PD-L1 or anti-PD-L2 antibody or inhibitory antisense RNA to PD-1, PD-L1 or PD-L2. Also disclosed is a method of activating T-cells comprising contacting T-cells with a viral antigen of interest in the presence of a PD-1 antagonist.
Patent NZ-579781-A (NZ)
Title: Scaffolding prop with connecting assembly including pivoting lock element
Inventor: KRELLER HELMUT
IPC: E04G1/14
Filed: 2008-03-27
Abstract: A prop (32.1) for a three-dimensional framework, particularly a scaffold, comprising a fastening mechanism for attaching a railing device (28.1, 28.2) to the prop. The fastening mechanism comprises a locking element (45) which can be swiveled about a swivel pin. In the locked position, the locking surface of the locking element lies across from a bearing surface of a support element (42) that is mounted on the prop. Furthermore, in the locked position and in the operational position of the prop, the locking surface of the locking element is disposed at a vertical distance above the bearing surface of the support element, and/or in the operational position of the prop, the swivel pin is placed at a vertical distance above the locking surface that is in the locking position, preferably also at a vertical distance above the bearing surface of the support element.
Patent NZ-580637-A (NZ)
Title: Isoquinolinone derivatives as nk3 antagonists
Inventor: KEHLER JAN
IPC: C07D403/06
Filed: 2008-04-24
Abstract: Provided is an isoquinolinone derivative as shown in formula (I), with specified substituents. The compound is useful as NK3 antagonist for the treatment of various diseases, including neuronal disorders, pulmonary diseases and gut inflammation.
Patent NZ-581947-A (NZ)
Title: Process and plant for incinerating waste with pure oxygen with preheating of the latter with steam tapped from an expansion turbine
Inventor: SIGERGOK HASAN
IPC: F23G5/00
Filed: 2008-05-16
Abstract: The disclosure relates to a process for incinerating domestic or industrial waste, in a reactor (RC), characterized in that: the combustion is carried out under pressure and with a supply of pure oxygen in the reactor, and in the absence of nitrogen, the vapours resulting from the steam expansion turbine are withdrawn in order to preheat the waste before entry thereof into the reactor, then the remaining gases are condensed with a view to the recovery thereof. A plant carrying out the process mainly comprises an incineration line (1), a vapour circuit (2), a fuel supply line (3), a nitrogen circuit (4) and an oxygen circuit.
Patent NZ-582769-A (NZ)
Title: Diagnosis and monitoring of inflammation, ischemia and appendicitis
Inventor: BAR-OR DAVID
IPC: A61B5/0402
Filed: 2003-10-02
Abstract: Provided is a method of diagnosing or monitoring inflammation in an animal comprising: (a) determining the quantity of cysteinylated albumin present in a sample of a body fluid of the animal, wherein the body fluid is blood, serum or plasma; and (b) determining if the quantity of the cysteinylated albumin is significantly altered compared to its level in the same body fluid from normal animals to determine if inflammation is present. Further provided are antibodies and aptamers for practising the method.
Patent NZ-585084-A (NZ)
Title: Methods and apparatus for handling microbial samples
Inventor: VAN DER KAAP TRIENKO MARTEN
IPC: C12M1/32
Filed: 2008-11-04
Abstract: The disclosure pertains to the general field of microbiology, and more specifically to transfer, inoculation and/or streaking of micro-organisms, e.g. for the purpose of obtaining individual colonies. Provided is a method for streaking a microbial sample onto a solid carrier, comprising the steps of: a) contacting at least one ferromagnetic particle with a solid carrier, followed or preceded by providing the particle with at least part of said sample, and b) applying a magnetic field gradient to allow for magnetically controlled motion of said particle on said surface, such that at least part of the sample is streaked onto the solid carrier. Also provided is an apparatus for carrying out such method in an (semi-)automated fashion.
Patent NZ-589195-A (NZ)
Title: Crystalline solvates and complexes of (1s)-1,5-anhydro-1-c-(3-((phenyl) methyl) phenyl)-d-glucitol derivatives with amino acids as sglt2 inhibitors for the treatment of diabetes
Inventor: GOUGOUTAS JACK Z
IPC: C07H7/04
Filed: 2007-06-21
Abstract: Disclosed is a crystalline structure of (1S)-1,5-anhydro-1-C-(3-((phenyl) methyl) phenyl)-D-glucitol of the formula (I) Also disclosed is the use of the crystalline structure as for the manufacture of a medicament for treating diabetes, insulin resistance, hyperglycemia, hyperinsulinemia, elevated blood levels of fatty acids or glycerol, hyperlipidemia, dyslipidemia, obesity, hypertriglyceridemia, or diabetic complications and a process of preparing the crystalline compound comprising dissolving the pentaacylated derivative of the glucitol in water: ethylene glycol from about 1:1 to about 0.4:1 and heating.
Patent NZ-593991-A (NZ)
Title: Manufacturing process to produce a necked container
Inventor: MYERS GARY L
IPC: B21D51/26
Filed: 2007-05-14
Abstract: A necking system comprising a plurality of necking dies configured for use on a metal bottle stock, where at least one necking die comprises a necking surface 10 and a relief 20, and where the necking surface 10 comprises a land portion 13, a neck radius portion 12, and a shoulder radius portion 11, each having an inner diameter. The land portion 13 which is between the neck radius portion 10 and the relief 20 has the minimum inner diameter of the die. The necking die is dimensioned so that when necking the metal bottle stock, the entire land 13 and the relief 20 travel relative to the bottle stock in an axial direction and at least a portion of the relief 20 travels beyond a top of the bottle stock. The land 13 has a surface finish Ra ranging from about 8 ìin to about 32 ìin.
Patent NZ-594201-A (NZ)
Title: Flue-gas analysis safety apparatus
Inventor: CRAWFORD RICHARD JAMES
IPC: F23N1/02
Filed: 2009-07-22
Abstract: 594201 Flue-gas analysis safety apparatus (10) for a gas or oil-fired device having an electrical connection and a flue for combustion gases, comprises a hazardous gas detection element (12) for placement in the flue to monitor flue gas, and a controller (14) for automatically regulating a gas to air ratio in the flue gas based on a signal from the hazardous gas detection element. The hazardous gas detection element includes an elongate wand (18) having a hazardous gas sensor at a distal end. The controller is able to halt a flow of electricity to the gas or oil-fired device if the gas to air ratio in the flue gas cannot be regulated to fall within a predetermined safe parameter. Preferably, the hazardous gas detection element includes a wireless transmitter, and the controller includes a wireless receiver so that the hazardous gas detection element is wirelessly communicable with the controller. A gas or oil-fired device having the apparatus, and a method are also provided.
Patent NZ-594639-A (NZ)
Title: Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
Inventor: SHROFF GEETA
IPC: C12N5/0735
Filed: 2007-03-06
Abstract: 594639 Disclosed is the use of human embryonic stem cells (hES) cells and/or their derivatives, said cells being free from animal products, feeder cells, growth factors other than beta-hCG and progesterone, leukaemia inhibiting factors, fibroblast growth factor, vitamin supplements, membrane associated steel factor, soluble steel factor and conditioned media, for the preparation of a medicament for the treatment of a subject with a disease, disorder, or condition selected from the group consisting of spinal cord injury, developmental disorders of the nervous system, degenerative disorders, familial nervous system disorders, nervous system trauma, cerebrovascular attack, skin disorders, bed sores, autoimmune disorders, genetic disorders, gangrene, conditions associated with ageing, diabetes mellitus, cardiovascular disorders, liver disorders, kidney disorders, fertility disorders, reproductive disorders, musculoskeletal disorders, eye disorders, lung disorders, hormone disorders, aphthous ulcers, other ulcers, and osteo-arthritis of the knee and hip joint, wherein the hES cells are not totipotent.
Patent NZ-594757-A (NZ)
Title: Payment card having acceptance attributes on a single side
Inventor: LOUGHRAN MARGARET
Filed: 2010-02-19
Abstract: 594757 Disclosed is a payment card. The payment card has a generally planar body having a first side and a second side, having a conventional form factor (as described in ISO/IEC 7810 ID-1) and a plurality of acceptance attributes on the second side. The first side is formed without any acceptance attributes thereon. The first side may include artwork of an issuer of the payment card. The acceptance attributes may include, for example, a signature panel, a cardholder name, and a card expiration date, at least one of a bar code and a magnetic stripe, and a card security code. A method of using such a card includes physically presenting the card to a merchant, and viewing, by the merchant, of at least needed ones of the acceptance attributes without the merchant being required to turn the card over. Another method of using such a card includes supplying (without necessarily physically presenting the card), from a card user to a merchant, acceptance attribute information of a payment card of the kind described, as well as viewing, by the card user, of the acceptance attribute information without the card user being required to turn the card over.
Patent NZ-597252-A (NZ)
Title: Compounds for inhibiting mitotic progression
Inventor: CLAIBORNE CHRISTOPHER F
IPC: A61K31/55
Filed: 2007-11-14
Abstract: 597252 Disclosed herein is the use of a therapeutically effective amount of an Aurora kinase inhibitor in the manufacture of a pharmaceutical composition for treating cancer in a patient in need thereof, wherein the Aurora kinase inhibitor is the compound 4- { [9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino} -2-methoxybenzoic acid or a pharmaceutically acceptable salt thereof; and wherein the cancer is: bladder cancer; renal cancer; hepatocellular cancer; lung cancer; cervical cancer; esophageal cancer; head and neck cancer; melanoma; neuroendocrine cancer; brain tumor; bone cancer; soft tissue sarcoma; progressive epithelial or primary peritoneal cancer; metastatic breast cancer; androgen-dependent or androgen-independent prostate cancer; metastatic renal cell carcinoma; non-small cell lung cancer; bronchioloalveolar carcinoma; adenocarcinoma of the lung; squamous cell carcinoma of the head and neck; metastatic neuroendocrine tumors; glioma; anaplastic oligodendroglioma; adult glioblastoma multiforme; or adult anaplastic astrocytoma; or a hematological malignancy selected from the group consisting of acute myeloid leukemia; chronic myelogenous leukemia, including accelerated CML and CML blast phase; acute lymphoblastic leukemia; chronic lymphocytic leukemia; Hodgkin's disease; nonHodgkin's lymphoma, including follicular lymphoma and mantle cell lymphoma; B-cell lymphoma; T-cell lymphoma; multiple myeloma; Waldenstrom's macroglobulinemia; myelodysplastic syndromes, including refractory anemia, refractory anemia with ringed siderblasts, refractory anemia with excess blasts, RAEB in transformation; and myeloproliferative syndromes. Specifically, wherein the aurora kinase inhibitor is sodium 4-{ [9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino} -2-methoxybenzoate.
Patent NZ-601291-A (NZ)
Title: Radio base station and user equipment and methods therein
Inventor: GERSTENBERGER DIRK
IPC: H04L5/00
Filed: 2011-01-18
Abstract: Disclosed is a user equipment (10) for transmitting uplink control information in time slots in a sub-frame over a radio channel to a radio base station (12). The radio channel is arranged to carry uplink control information, and the uplink control information is comprised in a block of bits. The user equipment (10) includes a mapping circuit (213) configured to map the block of bits to a sequence of complex valued modulation symbols. A block spreading circuit (214) is configured to block spread the sequence of complex valued modulation symbols across Discrete Fourier Transform Spread - Orthogonal Frequency Division Multiplexing, DFTS-OFDM, symbols by applying a spreading sequence to the sequence of complex valued modulation symbols. The result of this is to achieve a block spread sequence of complex valued modulation symbols. A transforming circuit (215) is configured to transform, per DFTS-OFDM symbol, the block-spread sequence of complex valued modulation symbols by applying a matrix with matrix elements. The matrix elements are cyclically shifted depending on a DFTS-OFDM symbol index and/or slot index, to the block-spread sequence of complex valued modulation symbols. A transmitter (217) is configured to transmit the block spread sequence of complex valued modulation symbols that has been transformed over the radio channel to the radio base station (12).
Patent NZ-603673-A (NZ)
Title: Machine for producing packaging cushioning
Inventor: MIERZEJEWSKI KENNETH J
IPC: B65H7/02
Filed: 2011-05-18
Abstract: 603673 A machine (10) for producing packaging cushioning is disclosed. The machine includes a first feed mechanism (12) for successively feeding sheets (18) of a substrate at a first speed, the first feed mechanism (12) including a motor (M1) and a power supply (100 - Fig.13) therefor, a second feed mechanism (14) for receiving the sheets from the first feed mechanism and feeding the sheets at a second speed, a control unit (16) for controlling at least one of the first and second speeds to produce a desired degree of overlap (26) between successive sheets, and a sensor (112 – Fig.13) to measure the amount of electricity drawn by the motor. The control unit modulates the amount of electricity that the motor draws from a power supply when a signal from the sensor has a value that is greater than or equal to a predetermined value. When operated in the foregoing manner the machine was able to produce packaging cushions of various densities while avoiding about 95% of all paper jams that would otherwise have been caused by overlaps.
Patent NZ-610473-A (NZ)
Title: Adjuvants for insecticides
Inventor: HAZEN JAMES LYLE
IPC: A01N25/30
Filed: 2011-12-09
Abstract: Disclosed is an insecticide composition comprising an insectidally active agent and one or more alkoxylated fatty amines of formulae I-V. The formulation enhances the activity of certain insecticides when applied to the exterior foliage of a plant, thus increasing the kill rate of feeding insects that are normally protected deep within other tissue structures of the plant.
Patent NZ-612080-A (NZ)
Title: Anthelmintic compositions
Inventor: HALLIGAN DOUGLAS GRANT
IPC: A01N53/00
Filed: 2012-05-01
Abstract: Disclosed herein is a stable anthelmintic composition including: (i) micronized macrocyclic lactone particles, wherein the particles in are less than 100μm in size; (ii) polyethylene glycol with average molecular weight of 6000-8000 as a suspension aid; and (iii) water.
Patent NZ-616199-A (NZ)
Title: Production of soluble protein solutions from soy (“s701”)
Inventor: LOGIE JAMES
IPC: A23L11/30
Filed: 2009-10-21
Abstract: Disclosed is a soy protein product having a protein content of at least 60 wt% (N x 6.25) d.b. which is substantially completely soluble in an aqueous medium at a pH of less than 4.4 as determined by the pellet method, in accordance with the relationship: solubility (%) = (1- (weight dry insoluble pellet material/((weight of 20 ml of dispersion/weight of 50 ml of dispersion) x initial weight dry protein powder))) x 100 and by the protein method, in accordance with the relationship: solubility (%) = (% protein in supernatant/% protein in initial dispersion) x 100.
Patent NZ-625371-A (NZ)
Title: Stabilized concentrated liquid human milk fortifier
Inventor: VURMA MUSTAFA
IPC: A23L33/00
Filed: 2012-12-03
Abstract: Provided are shelf-stable concentrated liquid human milk fortifier compositions comprising extensively hydrolyzed casein and octenyl succinic acid (OSA) modified waxy potato starch. The OSA acts as a stabilizer for the compositions preventing the hardening of fat globules and the sedimentation of minerals in the fortifier. Further provided is a method of fortifying breast milk by mixing it with the concentrated liquid human milk fortifier compositions.
Patent NZ-625767-A (NZ)
Title: System and method for event timing and photography
Inventor: TODD MARTIN
IPC: G06Q50/10
Filed: 2014-06-03
Abstract: A system and method for identifying and timing an athlete (126) during a timed sporting event. The athlete (126) is timed using image recognition technology in which one or more images of the athlete taken during the sporting event is time-stamped to generate a finish time for the athlete (126). The athlete (126) is identified by comparing one of the images taken during the sporting event with a profile image of the athlete.
Patent NZ-703071-A (NZ)
Title: Method for the production of a porous powder product containing a probiotic or other microorganisms
Inventor: COLLADO MAXIME
IPC: A23L29/00
Filed: 2013-03-22
Abstract: A method for the production of a porous powder product containing a microorganism, from a liquid concentrate comprising at least one liquid microorganism culture and a carrier composition is disclosed. The carrier composition comprises at least one carbohydrate and at least one protein. The method comprises steps of preparing the liquid concentrate to a temperature of between 5 and 40°C to have a viscosity greater than 150 mPa.s at that temperature; injecting a food grade gas into the prepared concentrate at a pressure greater than 0.3 MPa to intimately incorporate the gas into the liquid concentrate and form a stable foam with a density of between about 0.6 to about 1.2 kg/l; conveying the foam to an atomizing device where the pressure of the foam is reduced from 0.3 MPa to atmospheric pressure to provide a partially dried product; and exposing the partially dried product to a drying media to reduce both the moisture content to less than 5% moisture and the water activity to less than 0.25 Aw, to provide the porous powder product. The porous powder product contains high levels of viable microorganism, while avoiding difficulties associated with freeze drying and high temperature techniques.